Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -375.77% is 11% above its 5-year average of -421.87%, around the middle of its 5-year range (-3065.38%–1266.58%).
16.47% below its 12-month average of -322.63%.
Reported quarterly profit margin; no daily interpolation. Q1 FY2026 (2026-03-31): 17.55%.
NET PROFIT MARGIN
-375.77%
NET PROFIT MARGIN AVG TTM
-322.63%
NET PROFIT MARGIN AVG 3Y
-198.43%
NET PROFIT MARGIN AVG 5Y
-421.87%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-16.47%
CURRENT VS 3Y AVG
-89.37%
CURRENT VS 5Y AVG
+10.93%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-107262.86%
vs the sector median at left
Celularity Inc.
Market Cap
$45.73M
Net Profit Margin
-375.77%
TTM Avg
-322.63%
3Y Avg
-198.43%
5Y Avg
-421.87%
Market Cap
$46.69M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-4557.73%
Market Cap
$44.72M
Net Profit Margin
-164.82%
TTM Avg
-1870.42%
3Y Avg
-1064.08%
5Y Avg
-709.38%
Market Cap
$44.71M
Net Profit Margin
32.60%
TTM Avg
-34.66%
3Y Avg
-64.33%
5Y Avg
-204.90%
Market Cap
$44.02M
Net Profit Margin
322.77%
TTM Avg
-172.32%
3Y Avg
-215.38%
5Y Avg
-270.73%
Market Cap
$47.98M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-9.50%
5Y Avg
-48.42%
Market Cap
$42.99M
Net Profit Margin
-84.93%
TTM Avg
-105.50%
3Y Avg
-125.06%
5Y Avg
-177.30%
Market Cap
$48.53M
Net Profit Margin
-128.69%
TTM Avg
-13664.85%
3Y Avg
-30726.86%
5Y Avg
-811138.03%
Market Cap
$42.83M
Net Profit Margin
-747.20%
TTM Avg
-525.22%
3Y Avg
-722.73%
5Y Avg
-1271.67%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celularity Inc. (CELU) | $45.73M | -375.77% | -322.63% | -198.43% | -421.87% |
| Instil Bio, Inc. (TIL)vs › | $46.69M | 0.00% | 0.00% | 0.00% | -4557.73% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | -164.82% | -1870.42% | -1064.08% | -709.38% |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 32.60% | -34.66% | -64.33% | -204.90% |
| DarioHealth Corp. (DRIO)vs › | $44.02M | 322.77% | -172.32% | -215.38% | -270.73% |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | 0.00% | 0.00% | -9.50% | -48.42% |
| CVRx, Inc. (CVRX)vs › | $42.99M | -84.93% | -105.50% | -125.06% | -177.30% |
| Apollomics, Inc. (APLM)vs › | $48.53M | -128.69% | -13664.85% | -30726.86% | -811138.03% |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | -747.20% | -525.22% | -722.73% | -1271.67% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $42.72M | -145.56% | -153.73% | -223.84% | -240.41% |
Operating Margin
-230.9%
Net Profit Margin
-375.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | 17.55% |
| 2025-12-31 | -593.62% |
| 2025-09-30 | -436.66% |
| 2025-06-30 | -427.55% |
| 2025-03-31 | -172.89% |
| 2024-12-31 | -73.31% |
| 2024-09-30 | -173.17% |
| 2024-06-30 | -53.57% |
| 2024-03-31 | -149.94% |
| 2023-12-31 | 78.82% |
| 2023-09-30 | -2479.56% |
| 2023-06-30 | -1632.03% |
| 2023-03-31 | -1626.86% |
| 2022-12-31 | 591.77% |
| 2022-09-30 | 116.06% |
| 2022-06-30 | 1266.58% |
| 2022-03-31 | -1059.26% |
| 2021-12-31 | -83.20% |
| 2021-09-30 | 470.14% |
| 2021-06-30 | -2016.80% |
| 2021-03-31 | -3065.38% |
| 2020-12-31 | 120.57% |
| 2020-09-30 | -1380.77% |
| 2020-06-30 | -3906.05% |
| 2020-03-31 | -717.68% |
| 2019-12-31 | -431.59% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
